{"id":"ferinject","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":["IV FCM","Ferric carboxymaltose","FCM","Colloidal solution of the iron complex ferric carboxymaltose","carboxymaltose ferrique"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-28T00:39:39.961Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Iron deficiency anemia","diseaseId":"iron-deficiency-anemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07476859","phase":"PHASE4","title":"Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome","status":"RECRUITING","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2026-03-05","conditions":"Acute Coronary Syndromes (ACS), Iron Deficiencies, Elderly (People Aged 65 or More)","enrollment":538},{"nctId":"NCT07414199","phase":"PHASE4","title":"The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department","status":"NOT_YET_RECRUITING","sponsor":"Children's Hospital of Orange County","startDate":"2026-01-31","conditions":"Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease, Iron Deficiency Anaemia Due to Dietary Causes, Iron Deficiency Anemia Treatment","enrollment":150},{"nctId":"NCT07384663","phase":"PHASE1","title":"EFFICACY OF IV VERSUS ORAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCY","status":"COMPLETED","sponsor":"Dr Salaha Azam","startDate":"2025-06-01","conditions":"Iron Deficiency Anaemia in Childbirth","enrollment":112},{"nctId":"NCT07359599","phase":"PHASE4","title":"The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension","status":"RECRUITING","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2026-01-27","conditions":"Pulmonary Hypertension, Iron Deficiency","enrollment":306},{"nctId":"NCT07370688","phase":"PHASE4","title":"Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2024-08-12","conditions":"Aortic Valve Stenosis, Iron Deficiency, TAVI(Transcatheter Aortic Valve Implantation)","enrollment":402},{"nctId":"NCT07340450","phase":"NA","title":"Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia","status":"COMPLETED","sponsor":"Shahida Islam Medical Complex","startDate":"2025-02-18","conditions":"Postpartum Anaemia","enrollment":122},{"nctId":"NCT03817957","phase":"PHASE3","title":"Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency","status":"COMPLETED","sponsor":"Prof. Dr. Frank Behrens","startDate":"2018-09-18","conditions":"Iron Deficiency Anemia","enrollment":187},{"nctId":"NCT05309499","phase":"NA","title":"An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function","status":"COMPLETED","sponsor":"Kazan State Medical University","startDate":"2021-12-05","conditions":"Myocardial Infarction, Iron-deficiency","enrollment":298},{"nctId":"NCT02632760","phase":"PHASE4","title":"Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery","status":"COMPLETED","sponsor":"Bayside Health","startDate":"2016-07-15","conditions":"Anaemia","enrollment":955},{"nctId":"NCT05793996","phase":"PHASE4","title":"The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)","status":"RECRUITING","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2023-04-28","conditions":"Chronic Heart Failure, Iron Deficiency, Latent","enrollment":100},{"nctId":"NCT06309641","phase":"","title":"Methemoglobinemia Following Intravenous Iron Treatment","status":"COMPLETED","sponsor":"Claudia Seiler","startDate":"2024-09-02","conditions":"Methemoglobinemia, Anemia, Iron Deficiencies","enrollment":50},{"nctId":"NCT07217873","phase":"PHASE2, PHASE3","title":"IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study","status":"RECRUITING","sponsor":"Columbia University","startDate":"2025-11-21","conditions":"Scoliosis Correction, Iron Deficiency, Transfusion Blood","enrollment":120},{"nctId":"NCT06958822","phase":"","title":"Ferric Carboxymaltose Methemoglobinemia Study","status":"COMPLETED","sponsor":"Ordu University","startDate":"2025-04-14","conditions":"Methemoglobinemia, Anemia, Iron-Deficiency, Parenteral Iron Therapy","enrollment":977},{"nctId":"NCT07115121","phase":"NA","title":"Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2025-02-02","conditions":"Anemia","enrollment":40},{"nctId":"NCT04915820","phase":"NA","title":"Iron and COVID-19 Vaccine Response","status":"COMPLETED","sponsor":"Jomo Kenyatta University of Agriculture and Technology","startDate":"2021-05-29","conditions":"Iron Deficiency Anemia, Vaccine Response Impaired, COVID-19 Vaccine","enrollment":121},{"nctId":"NCT05636774","phase":"NA","title":"Empower the Heart of Patients With Terminal Cancer Using Cardiac Medicines Trial","status":"COMPLETED","sponsor":"University Hospital, Essen","startDate":"2022-12-12","conditions":"Patients With Advanced Cancer Receiving Specialized Palliative Care","enrollment":97},{"nctId":"NCT04744181","phase":"","title":"Patient Blood Management In CARdiac sUrgical patientS","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-01-18","conditions":"Anemia, Blood Loss Anemia, Iron-deficiency","enrollment":479},{"nctId":"NCT06994065","phase":"NA","title":"Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients","status":"RECRUITING","sponsor":"Sindh Institute of Urology and Transplantation","startDate":"2025-06-02","conditions":"Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease","enrollment":128},{"nctId":"NCT06833788","phase":"PHASE4","title":"Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09","conditions":"Postpartum Depression (PPD)","enrollment":2860},{"nctId":"NCT05759078","phase":"PHASE4","title":"Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion","status":"RECRUITING","sponsor":"Wroclaw Medical University","startDate":"2022-09-22","conditions":"Myocardial Infarction, Acute","enrollment":1000},{"nctId":"NCT07057973","phase":"NA","title":"The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-07-01","conditions":"Ferric Carboxymaltose","enrollment":100},{"nctId":"NCT07053475","phase":"PHASE4","title":"IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches","status":"RECRUITING","sponsor":"Syed Hamza Mufarrih","startDate":"2025-04-02","conditions":"Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":250},{"nctId":"NCT01950247","phase":"PHASE4","title":"Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2013-08-15","conditions":"Iron Deficiency Anemia (IDA)","enrollment":1025},{"nctId":"NCT03833336","phase":"PHASE3","title":"Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)","status":"COMPLETED","sponsor":"Institut de Recerca Biomèdica de Lleida","startDate":"2017-08-23","conditions":"Heart Failure With Normal Ejection Fraction, Ferropenic Anemia","enrollment":72},{"nctId":"NCT06895993","phase":"PHASE1","title":"Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2025-04-07","conditions":"Healthy Adult","enrollment":84},{"nctId":"NCT00685815","phase":"PHASE2","title":"Intravenous Iron Metabolism in Restless Legs Syndrome","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2006-11","conditions":"Restless Legs","enrollment":12},{"nctId":"NCT06948864","phase":"","title":"Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia","status":"COMPLETED","sponsor":"Hospital Universitario Infanta Cristina","startDate":"2020-01-01","conditions":"Anemia, Anemia (Iron-Loading), Perioperative Bleeding","enrollment":152},{"nctId":"NCT05816265","phase":"PHASE4","title":"Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure","status":"ENROLLING_BY_INVITATION","sponsor":"Radha Gopalan","startDate":"2024-01-24","conditions":"Heart Failure, Iron-deficiency","enrollment":40},{"nctId":"NCT00740246","phase":"PHASE3","title":"Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-07","conditions":"Anemia","enrollment":594},{"nctId":"NCT05545527","phase":"","title":"Neuroimaging Ancillary Study","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2023-02-21","conditions":"Iron Deficiency Anemia, Iron Deficiency Anemia of Pregnancy, Neurodevelopmental Disorder of Foetus","enrollment":184},{"nctId":"NCT04343170","phase":"NA","title":"Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-09-01","conditions":"Ultra-short-term, Iron Deficiency Anemia, Scoliosis Idiopathic","enrollment":44},{"nctId":"NCT04625530","phase":"PHASE3","title":"Perioperative Management in Gynaecological Carcinoma Surgery","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-08-01","conditions":"Gynaecological Carcinoma","enrollment":""},{"nctId":"NCT02826681","phase":"PHASE2","title":"Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia","status":"TERMINATED","sponsor":"American Regent, Inc.","startDate":"2017-07-10","conditions":"Restless Legs Syndrome (RLS)","enrollment":70},{"nctId":"NCT06911034","phase":"PHASE4","title":"Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women","status":"COMPLETED","sponsor":"CMH Multan Institute of Medical Sciences","startDate":"2024-02-01","conditions":"Iron Deficiency Anemia (IDA), Pregnancy","enrollment":60},{"nctId":"NCT06686693","phase":"PHASE4","title":"Intravenous Iron Effects on Performance at High Altitude","status":"RECRUITING","sponsor":"United States Army Research Institute of Environmental Medicine","startDate":"2022-04-15","conditions":"Hypoxia","enrollment":24},{"nctId":"NCT05060731","phase":"PHASE4","title":"Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding","status":"NOT_YET_RECRUITING","sponsor":"University of Pecs","startDate":"2025-09-01","conditions":"GastroIntestinal Bleeding, Anemia","enrollment":570},{"nctId":"NCT06080893","phase":"PHASE4","title":"The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2023-10-10","conditions":"Hip Fractures, Anemia, Complication,Postoperative","enrollment":209},{"nctId":"NCT06883201","phase":"","title":"Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer","status":"RECRUITING","sponsor":"Regina Elena Cancer Institute","startDate":"2023-01-31","conditions":"Breast Cancer","enrollment":78},{"nctId":"NCT06437080","phase":"NA","title":"Hypoferritinemia Without Anemia Among Reproductive Age Females","status":"ACTIVE_NOT_RECRUITING","sponsor":"Akram Medical Complex","startDate":"2022-10-10","conditions":"Hypoferritenemia Without Anemia (HWA), Iron Deficiency Without Anemia)","enrollment":1331},{"nctId":"NCT03680456","phase":"PHASE4","title":"Postoperative Replacement of Intraoperative Iron Losses","status":"COMPLETED","sponsor":"Kepler University Hospital","startDate":"2020-03-06","conditions":"Blood Loss Anemia","enrollment":134},{"nctId":"NCT03036462","phase":"PHASE4","title":"Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2017-03-07","conditions":"Systolic Heart Failure, Iron Deficiency","enrollment":1105},{"nctId":"NCT03231085","phase":"NA","title":"Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2017-10-31","conditions":"Craniosynostosis","enrollment":100},{"nctId":"NCT05744219","phase":"PHASE3","title":"Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial","status":"RECRUITING","sponsor":"Jon Unosson","startDate":"2024-09-04","conditions":"Surgery, Liver Metastases, Liver Cancer","enrollment":338},{"nctId":"NCT04087993","phase":"PHASE3","title":"Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients","status":"WITHDRAWN","sponsor":"Dr. Frank Behrens","startDate":"2020-05-15","conditions":"Iron Deficiency Anemia","enrollment":""},{"nctId":"NCT03769441","phase":"PHASE3","title":"Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2019-08-02","conditions":"Iron-deficiency, Transplant-Related Disorder","enrollment":148},{"nctId":"NCT06350955","phase":"PHASE4","title":"IV Iron-induced Hypophosphatemia After RYGB","status":"RECRUITING","sponsor":"Lucie Favre","startDate":"2024-05-02","conditions":"Hypophosphatemia, Roux-en-Y Gastric Bypass","enrollment":94},{"nctId":"NCT06542393","phase":"PHASE2","title":"PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)","status":"RECRUITING","sponsor":"Federal University of São Paulo","startDate":"2024-06-01","conditions":"Anemia, Coronary Disease, Coronary Artery Disease","enrollment":120},{"nctId":"NCT03037931","phase":"PHASE3","title":"Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2017-03-15","conditions":"Heart Failure, Iron-deficiency","enrollment":3065},{"nctId":"NCT06442111","phase":"NA","title":"The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy","status":"NOT_YET_RECRUITING","sponsor":"Seoul St. Mary's Hospital","startDate":"2024-07-01","conditions":"Pancreaticojuodenectomy","enrollment":106},{"nctId":"NCT06434025","phase":"PHASE3","title":"IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency","status":"NOT_YET_RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2024-05-24","conditions":"Heart Failure, Systolic, Iron Deficiencies","enrollment":99},{"nctId":"NCT03074591","phase":"PHASE4","title":"Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2017-08-01","conditions":"Iron-deficiency, Heart Failure","enrollment":40},{"nctId":"NCT05358509","phase":"PHASE4","title":"Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2021-03-15","conditions":"Iron Deficiency Anemia, Infant, Low Birth Weight, Anemia of Pregnancy","enrollment":4368},{"nctId":"NCT06080555","phase":"PHASE1","title":"Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2023-10-09","conditions":"Iron Deficiency, Anaemia","enrollment":84},{"nctId":"NCT04653181","phase":"NA","title":"Preoperative i.v. Iron Substitution in Patients With Colon Cancer","status":"UNKNOWN","sponsor":"Helsinki University Central Hospital","startDate":"2020-10-01","conditions":"Colon Cancer","enrollment":514},{"nctId":"NCT05226169","phase":"PHASE3","title":"Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2022-04-29","conditions":"Advanced Gastric Carcinoma","enrollment":330},{"nctId":"NCT03991000","phase":"PHASE3","title":"Iron in Patients With Cardiovascular Disease","status":"TERMINATED","sponsor":"Dr. med. Mahir Karakas","startDate":"2019-02-28","conditions":"Cardiovascular Diseases, Anemia, Iron-deficiency, Acute Myocardial Infarction","enrollment":8},{"nctId":"NCT05702970","phase":"PHASE4","title":"Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2024-01-15","conditions":"Heart Failure, Iron-deficiency, Heart Failure, Systolic","enrollment":258},{"nctId":"NCT05504863","phase":"","title":"RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2022-10-11","conditions":"Iron Deficiency Anemia, Neurodevelopmental Abnormality, Autism Spectrum Disorder","enrollment":538},{"nctId":"NCT06061393","phase":"PHASE4","title":"Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia","status":"UNKNOWN","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2023-10-30","conditions":"Anemia, Iron Deficiency, Pregnancy Anemia","enrollment":200},{"nctId":"NCT02694978","phase":"PHASE3","title":"A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2016-02-29","conditions":"Iron Deficiency Anemia","enrollment":2014},{"nctId":"NCT04976179","phase":"PHASE3","title":"Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)","status":"COMPLETED","sponsor":"University of Lagos, Nigeria","startDate":"2021-08-09","conditions":"Iron Deficiency Anemia of Pregnancy","enrollment":1056},{"nctId":"NCT03218384","phase":"PHASE2","title":"Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2017-09-07","conditions":"Iron-deficiency","enrollment":20},{"nctId":"NCT05098249","phase":"PHASE4","title":"Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Donat R. Spahn","startDate":"2021-11-11","conditions":"Anemia, Iron-deficiency, Hypophosphatemia","enrollment":92},{"nctId":"NCT05187637","phase":"","title":".Patient Blood Management Program in Liver Transplantation","status":"UNKNOWN","sponsor":"Hospital Universitari de Bellvitge","startDate":"2022-03-23","conditions":"Iron Deficiency Anemia","enrollment":66},{"nctId":"NCT04355130","phase":"","title":"Autologous Tansfusion REquirements in Bone MArrow Harvest: The ATREMA Study","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2020-03-20","conditions":"Bone Marrow Donors","enrollment":7},{"nctId":"NCT05708170","phase":"PHASE4","title":"Impact of Intravenous Iron on Musculoskeletal Function in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Liverpool Hope University","startDate":"2023-01","conditions":"Iron Deficiency Anemia","enrollment":100},{"nctId":"NCT04968379","phase":"PHASE2","title":"Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia","status":"WITHDRAWN","sponsor":"American Regent, Inc.","startDate":"2022-07-21","conditions":"Iron Deficiency, Anaemia","enrollment":""},{"nctId":"NCT05669872","phase":"NA","title":"Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2023-02","conditions":"Gynecologic Cancer","enrollment":334},{"nctId":"NCT04083755","phase":"PHASE4","title":"Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)","status":"UNKNOWN","sponsor":"Biobizkaia Health Research Institute","startDate":"2019-08-15","conditions":"Anemia, Peripheral Arterial Occlusive Disease","enrollment":240},{"nctId":"NCT05000853","phase":"","title":"New Pathophysiological Pathways Involved in Iron Metabolism Disorder in Heart Failure","status":"UNKNOWN","sponsor":"Hospital Universitari de Bellvitge","startDate":"2021-08-01","conditions":"Heart Failure","enrollment":210},{"nctId":"NCT04141631","phase":"NA","title":"Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2020-01-13","conditions":"Cardiac Surgery, Transfusion, Perioperative Anemia","enrollment":128},{"nctId":"NCT05581420","phase":"NA","title":"Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2022-06-02","conditions":"Inflammatory Bowel Diseases","enrollment":152},{"nctId":"NCT03632525","phase":"PHASE4","title":"Intravenous Iron in Adults With Cystic Fibrosis","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-02-22","conditions":"Cystic Fibrosis, Iron-deficiency","enrollment":20},{"nctId":"NCT01975272","phase":"PHASE4","title":"The Use of Iron Therapy for Patients With Anemia After Caesarean Section","status":"TERMINATED","sponsor":"Maastricht University Medical Center","startDate":"2015-03-02","conditions":"Postoperative Anaemia","enrollment":27},{"nctId":"NCT05505006","phase":"PHASE4","title":"Management of Preoperative Anaemia in Surgical Oncology","status":"UNKNOWN","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2021-03-02","conditions":"Anemia, Tumor","enrollment":500},{"nctId":"NCT03388385","phase":"PHASE4","title":"Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD","status":"UNKNOWN","sponsor":"Carol Davila University of Medicine and Pharmacy","startDate":"2017-09-20","conditions":"Renal Anemia, Iron Toxicity, Oxidative Stress","enrollment":40},{"nctId":"NCT03541213","phase":"NA","title":"Impact of Iron Deficiency and Its Correction on Mitochondrial Metabolism of the Cardiomyocyte (MitoCardioFer)","status":"COMPLETED","sponsor":"University Hospital, Angers","startDate":"2019-01-23","conditions":"Iron-deficiency, Valvular Heart Disease","enrollment":55},{"nctId":"NCT05477498","phase":"PHASE4","title":"Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction","status":"WITHDRAWN","sponsor":"Cantonal Hosptal, Baselland","startDate":"2021-12-01","conditions":"Heart Failure With Normal Ejection Fraction, Iron-deficiency","enrollment":""},{"nctId":"NCT02410213","phase":"PHASE2","title":"A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2015-02-19","conditions":"Iron Deficiency Anemia (IDA)","enrollment":35},{"nctId":"NCT02308449","phase":"NA","title":"Iron Status and Human Metabolism","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2014-10","conditions":"Iron Deficiency","enrollment":29},{"nctId":"NCT03957057","phase":"PHASE3","title":"Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-09-10","conditions":"Postpartum Anemia Nos, Iron-deficiency","enrollment":300},{"nctId":"NCT05429749","phase":"PHASE4","title":"Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2020-07-30","conditions":"Hip Fractures","enrollment":264},{"nctId":"NCT03523117","phase":"PHASE3","title":"Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2019-01-31","conditions":"Iron Deficiency Anemia","enrollment":79},{"nctId":"NCT01100879","phase":"PHASE4","title":"Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy","status":"TERMINATED","sponsor":"Vifor Pharma","startDate":"2010-03","conditions":"Iron-Deficiency Anemia","enrollment":3},{"nctId":"NCT04269707","phase":"PHASE3","title":"Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2019-11-19","conditions":"Iron Deficiency Anemia","enrollment":7},{"nctId":"NCT01447628","phase":"PHASE2","title":"IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2011-03-29","conditions":"Pulmonary Arterial Hypertension, Iron Deficiency","enrollment":56},{"nctId":"NCT04862715","phase":"PHASE4","title":"The Iron and Muscle Study","status":"COMPLETED","sponsor":"King's College Hospital NHS Trust","startDate":"2019-04-26","conditions":"CKD Stage 3, CKD Stage 4, Iron-deficiency","enrollment":75},{"nctId":"NCT05114278","phase":"PHASE4","title":"Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-02-15","conditions":"Celiac Disease","enrollment":204},{"nctId":"NCT04246021","phase":"NA","title":"Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy","status":"COMPLETED","sponsor":"King Hussein Cancer Center","startDate":"2016-06-15","conditions":"Anemia, Cancer","enrollment":84},{"nctId":"NCT00520780","phase":"PHASE3","title":"Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)","status":"COMPLETED","sponsor":"Vifor Pharma","startDate":"2007-04","conditions":"Chronic Heart Failure, Iron Deficiency, Iron Deficiency Anemia","enrollment":456},{"nctId":"NCT02397057","phase":"PHASE3","title":"Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2015-01","conditions":"Restless Legs Syndrome (RLS)","enrollment":209},{"nctId":"NCT03759964","phase":"PHASE4","title":"Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery","status":"COMPLETED","sponsor":"St Joseph University, Beirut, Lebanon","startDate":"2018-12-15","conditions":"Anemia, Iron Deficiency","enrollment":194},{"nctId":"NCT04631679","phase":"","title":"Investigation of the Wash-out Effect of Intravenous Iron by Cell Savers (WASH-OUT)","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2019-11-08","conditions":"Anemia, Anemia, Iron Deficiency, Iron Deficiency Anemia Treatment","enrollment":23},{"nctId":"NCT04912661","phase":"NA","title":"Iron and Vaccine Response","status":"COMPLETED","sponsor":"Swiss Federal Institute of Technology","startDate":"2021-05-29","conditions":"Iron Deficiency Anemia, Vaccine Preventable Disease, Vaccine Response Impaired","enrollment":121},{"nctId":"NCT03380520","phase":"PHASE4","title":"Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy","status":"COMPLETED","sponsor":"Hasselt University","startDate":"2017-10-01","conditions":"Heart Failure","enrollment":75},{"nctId":"NCT04974021","phase":"","title":"Iron Intravenous Therapy in Reducing the Burden of Severe Arrhythmias in Heart Failure With Reduced Ejection Fraction","status":"UNKNOWN","sponsor":"Aristotle University Of Thessaloniki","startDate":"2019-06-20","conditions":"Ferric Carboxymaltose, Heart Failure With Reduced Ejection Fraction, Arrhythmias, Cardiac","enrollment":106},{"nctId":"NCT02937454","phase":"PHASE4","title":"Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2017-04-03","conditions":"Iron Deficiency, Heart Failure","enrollment":1132},{"nctId":"NCT03591406","phase":"PHASE3","title":"To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2017-07-03","conditions":"Iron Deficiency Anemia","enrollment":371},{"nctId":"NCT04898569","phase":"PHASE4","title":"Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2019-02-10","conditions":"Coronary Artery Disease","enrollment":100},{"nctId":"NCT02453334","phase":"PHASE3","title":"Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2015-05-23","conditions":"Cancer and Chemotherapy Related Anemia","enrollment":244}],"_emaApprovals":[],"_faersSignals":[{"count":461,"reaction":"DYSPNOEA"},{"count":421,"reaction":"MATERNAL EXPOSURE DURING PREGNANCY"},{"count":421,"reaction":"NAUSEA"},{"count":290,"reaction":"HEADACHE"},{"count":282,"reaction":"MALAISE"},{"count":275,"reaction":"PRURITUS"},{"count":274,"reaction":"DIZZINESS"},{"count":272,"reaction":"PYREXIA"},{"count":272,"reaction":"VOMITING"},{"count":265,"reaction":"HYPOPHOSPHATAEMIA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":77,"therapeuticAreas":["Hematology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Ferinject","genericName":"Ferinject","companyName":"Asan Medical Center","companyId":"asan-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":11,"withResults":2},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}